Targeting the CCL5/CCR5 Axis in Tumor-Stromal Crosstalk to Overcome Cisplatin Resistance in Neuroendocrine Prostate Cancer

Scientists established a neuroendocrine prostate cancer mouse allograft model and performed RNA sequencing to identify genes associated with cisplatin resistance.